Bioequivalence Study of Perindopril Tablets in Healthy Volunteers Under Fasting Conditions
Condition(s):BioequivalenceLast Updated:January 19, 2024Recruiting
Include Studies Not Open or Pending
Condition(s):BioequivalenceLast Updated:January 19, 2024Recruiting
Condition(s):BioequivalenceLast Updated:July 11, 2023Recruiting
Condition(s):Alzheimer’s DiseaseLast Updated:May 4, 2022Recruiting
Condition(s):Arterial Hypertension; HTNLast Updated:March 10, 2023Not yet recruiting
Condition(s):Arterial Hypertension; HTNLast Updated:February 14, 2024Not yet recruiting
Condition(s):Primary HypertensionLast Updated:January 13, 2023Recruiting
Condition(s):Renal Insufficiency, Chronic; Diabetic Nephropathy Type 2Last Updated:October 28, 2022Recruiting
Condition(s):Sacubitril/Valsartan; Hypertension; ObesityLast Updated:August 8, 2023Recruiting
Condition(s):Breast Feeding; Hypertension; Heart Failure; ProteinuriaLast Updated:October 18, 2023Recruiting
Condition(s):Cardiovascular DiseasesLast Updated:October 4, 2022Not yet recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.